bpc-157 tissue healing inquiry BPC-157: A Peptide with Remarkable Potential Frontiers | Stable Gastric Pentadecapeptide

The conclusion they came to is that when looking at the mental benefits, oral administration wins

All HPLC raw data included with every result

No robust randomised controlled trial of a chemically verified BPC-157 plus Ac-LKKTETQ TB-500 formulation was identified in the literature reviewed for this article

The research described in this article has been published on a preprint server but has not yet been peer-reviewed by scientific or medical experts

Spinal Cord

WADA has banned BPC-157 because it falls into the category of a Non-Approved Substance with the potential to enhance performance through its regenerative capabilities